Radiation therapy prior to a pancreaticoduodenectomy for adenocarcinoma is associated with longer operative times and higher blood loss

BACKGROUND: Pancreatic adenocarcinoma is currently the fourth leading cause of cancer-related deaths in the United States. In patients with “borderline resectable” disease, current National Comprehensive Cancer Center guidelines recommend the use of neoadjuvant chemoradiation prior to a pancreaticod...

Descripción completa

Detalles Bibliográficos
Autores principales: Aploks, Krist, Kim, Minha, Stroever, Stephanie, Ostapenko, Alexander, Sim, Young Bo, Sooriyakumar, Ashwinkumar, Rahimi-Ardabily, Arash, Seshadri, Ramanathan, Dong, Xiang Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494586/
https://www.ncbi.nlm.nih.gov/pubmed/37701691
http://dx.doi.org/10.4240/wjgs.v15.i8.1663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494586/
https://www.ncbi.nlm.nih.gov/pubmed/37701691
http://dx.doi.org/10.4240/wjgs.v15.i8.1663

Ejemplares similares